AI assistant
Sending…
BIO KEY INTERNATIONAL INC — Director's Dealing 2017
Mar 20, 2017
35397_dirs_2017-03-20_8eb24491-d68d-4886-9d39-5f9128ee8903.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO KEY INTERNATIONAL INC (BKYI)
CIK: 0001019034
Period of Report: 2017-03-16
Reporting Person: DEPASQUALE MICHAEL W (Director, Pres., CEO & Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-16 | Stock Option (Right to Buy) | $2.65 | A | 250000 | Acquired | 2024-03-15 | Common Stock (250000) | Direct |
Footnotes
F1: The option vests in three equal annual installments on March 16, 2018, 2019 and 2020.
More from BIO KEY INTERNATIONAL INC
Earnings Release
2026
May 18
Regulatory Filings
2026
Apr 22
Earnings Release
2026
Apr 20
Report Publication Announcement
2026
Mar 31
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Capital/Financing Update
2025
Dec 2
Regulatory Filings
2025
Dec 2